loading...| Preferred Name |
Ceftizoxime |
|
| Synonyms |
SK&F 88373 2 |
|
| Definitions |
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D015296 |
|
| altLabel |
SK&F 88373 2 FK 749 FR13749 SKF-88373 SKF88373 SKF 88373 FK-749 FR 13749 SK&F 883732 Monosodium Salt, Ceftizoxime Cefizox 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))- Ceftizoxime Sodium Salt, Ceftizoxime Monosodium Sodium, Ceftizoxime FK749 FR-13749 Ceftizoxime Monosodium Salt SK&F 88373-2 |
|
| AQL |
AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C0037261 C0007560 C0016187 C0701023 C0037237 C0282391 C0016636 |
|
| DC |
1 |
|
| definition |
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. |
|
| DX |
19890101 |
|
| HN |
89 |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000096 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
C43C467DPE 26337D5X88 0 |
|
| isa | ||
| LT |
TRD |
|
| Machine permutation |
89 |
|
| Mapped from |
http://purl.bioontology.org/ontology/MESH/C121334 http://purl.bioontology.org/ontology/MESH/C054692 http://purl.bioontology.org/ontology/MESH/C079769 http://purl.bioontology.org/ontology/MESH/C041950 http://purl.bioontology.org/ontology/MESH/C510184 http://purl.bioontology.org/ontology/MESH/C049934 |
|
| MDA |
19880524 |
|
| MMR |
20170524 |
|
| MN |
D02.886.665.074.190.190.145 D03.633.100.300.249.190.190.145 D02.065.589.099.249.190.190.145 |
|
| notation |
D015296 |
|
| PA |
D000900 |
|
| prefLabel |
Ceftizoxime |
|
| RR |
68401-81-0 (Ceftizoxime) 26337D5X88 68401-82-1 (mono NA salt) |
|
| TERMUI |
T359719 T044971 T044972 T044970 T044968 T044973 T044974 T044969 T044967 |
|
| TH |
US NL NLM (1999) CA NLM (1990) FDA SRS (2014) JAN (19XX) UNK (19XX) INN (19XX) USAN (1980) USP (19XX) BAN (19XX) |
|
| tui |
T109 T195 |
|
| subClassOf |